Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 20/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9978449 | 1.00 | REN (0.56) | REN | |
| SCHEMBL9978743 | 1.00 | REN (0.56) | REN | |
| SCHEMBL9978492 | 0.92 | REN (0.54) | REN | |
| SCHEMBL9978494 | 0.92 | REN (0.54) | REN | |
| SCHEMBL9978382 | 0.92 | REN (0.58) | REN | |
| SCHEMBL4456027 | 0.92 | REN (0.54) | REN | |
| SCHEMBL4456020 | 0.92 | REN (0.54) | REN | |
| SCHEMBL9978360 | 0.92 | REN (0.54) | REN | |
| SCHEMBL9978514 | 0.92 | REN (0.54) | REN | |
| SCHEMBL2431429 | 0.89 | REN (0.53) | REN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011148392-A1 | PROCESS FOR THE PREPARATION OF (2S,4S,5S,7S)-N-(2-CARBAMYL-2- METHYLPROPYL)-5-AMINO-4-HYDROXY-2,7-DIISOPROPYL-8-[4-METHOXY-3-(3- METHOXYPROPOXY)PHENYL]-OCTANAMIDE HEMIFUMARATE AND ITS INTERMEDIATES THEREOF | MSN LABORATORIES LIMITED (IN) | 2011-12-01 | — | — | WO | claimed |
| EP-3013836-B1 | PREPARATION OF GRIGNARD REAGENTS USING A FLUIDIZED BED | PATHEON AUSTRIA GMBH & CO KG (AT) | 2018-06-20 | — | — | EP | disclosed |
| US-9550797-B2 | Preparation of Grignard reagents using a fluidized bed | PATHEON HOLDINGS I B.V. (NL) | 2017-01-24 | — | — | US | disclosed |
| US-9550797-B2 | Preparation of Grignard reagents using a fluidized bed | PATHEON HOLDINGS I B.V. (NL) | 2017-01-24 | — | — | US | disclosed |
| US-20160137669-A1 | PREPARATION OF GRIGNARD REAGENTS USING A FLUIDIZED BED | PATHEON HOLDINGS I B.V. (NL) | 2016-05-19 | — | — | US | disclosed |
| US-20160137669-A1 | PREPARATION OF GRIGNARD REAGENTS USING A FLUIDIZED BED | PATHEON HOLDINGS I B.V. (NL) | 2016-05-19 | — | — | US | disclosed |
| WO-2014207206-A1 | PREPARATION OF GRIGNARD REAGENTS USING A FLUIDIZED BED | DPX HOLDINGS B.V. (NL) | 2014-12-31 | — | — | WO | disclosed |
| WO-2011148392-A1 | PROCESS FOR THE PREPARATION OF (2S,4S,5S,7S)-N-(2-CARBAMYL-2- METHYLPROPYL)-5-AMINO-4-HYDROXY-2,7-DIISOPROPYL-8-[4-METHOXY-3-(3- METHOXYPROPOXY)PHENYL]-OCTANAMIDE HEMIFUMARATE AND ITS INTERMEDIATES THEREOF | MSN LABORATORIES LIMITED (IN) | 2011-12-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160137669-A1 | PREPARATION OF GRIGNARD REAGENTS USING A FLUIDIZED BED | GRM4, GRIA4, GRM2 | REN 527/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.